State of Alaska, Department of Revenue - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 204 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
State of Alaska, Department of Revenue ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,091
-23.3%
23,727
-4.2%
0.01%
-17.6%
Q2 2023$1,422
+46.9%
24,759
-4.1%
0.02%
+54.5%
Q1 2023$968
+32.1%
25,815
-1.3%
0.01%
+22.2%
Q4 2022$733
-99.9%
26,168
-1.1%
0.01%
-10.0%
Q3 2022$743,000
-24.9%
26,469
-6.9%
0.01%
-16.7%
Q2 2022$989,000
+7.5%
28,438
+11.0%
0.01%
+20.0%
Q1 2022$920,000
+51.8%
25,628
-1.6%
0.01%
+66.7%
Q4 2021$606,000
+18.4%
26,053
-3.4%
0.01%
+20.0%
Q3 2021$512,000
+0.2%
26,978
+6.3%
0.01%0.0%
Q2 2021$511,000
+12.8%
25,378
+2.5%
0.01%0.0%
Q1 2021$453,000
-20.8%
24,765
-13.0%
0.01%
-16.7%
Q4 2020$572,000
-10.8%
28,465
-16.8%
0.01%
-25.0%
Q3 2020$641,000
-10.2%
34,205
+7.5%
0.01%
-11.1%
Q2 2020$714,000
+51.6%
31,805
+0.1%
0.01%
+28.6%
Q1 2020$471,000
-5.6%
31,785
+22.9%
0.01%0.0%
Q4 2019$499,000
-5.0%
25,870
-2.3%
0.01%0.0%
Q3 2019$525,000
+107.5%
26,485
+120.8%
0.01%
+75.0%
Q2 2019$253,000
+6.8%
11,993
+3.0%
0.00%0.0%
Q1 2019$237,000
+3.0%
11,647
+0.6%
0.00%0.0%
Q4 2018$230,000
+1.3%
11,577
-2.2%
0.00%0.0%
Q3 2018$227,000
+26.8%
11,832
+0.9%
0.00%
+33.3%
Q2 2018$179,000
-16.0%
11,732
+3.0%
0.00%
-25.0%
Q1 2018$213,000
+57.8%
11,392
+61.5%
0.00%
+33.3%
Q4 2017$135,000
+7.1%
7,0520.0%0.00%
-50.0%
Q3 2017$126,000
+0.8%
7,0520.0%0.01%
-33.3%
Q2 2017$125,000
+119.3%
7,052
+77.2%
0.01%
+125.0%
Q1 2017$57,000
-19.7%
3,980
+2.1%
0.00%
-42.9%
Q4 2016$71,0003,9000.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders